Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Randy D'amico

Neurological Surgery Brooklyn, NY Medical Doctor

NPI 1376809582 CMS profile 7217388

374 Stockholm St, Brooklyn, NY 11237

Open in the dashboard

General payments

$112,182

168 records reported · program years 2019–2025

Research payments

$15,750

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$9,376 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Randy D'amico of Brooklyn, NY is reported in the CMS Open Payments database as having received $112,182 across 168 general payments and $15,750 in research payments paid to them. Separately, studies naming them as principal investigator received $9,376 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41,013 17
2024 General $50,225 45
2023 General $7,435 19
2023 Research $5,400 1
2022 General $10,427 32
2022 Research $10,350 1
2021 General $1,792 18
2020 General $1,065 32
2019 General $225 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Randy D'amico
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Randy D'amico were reported at $41,013. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Randy D'amico Neurological Surgery median Middle half National median
2019 $225 $582 $138–$3,006 $163
2020 $1,065 $294 $76–$2,174 $114
2021 $1,792 $387 $105–$2,432 $132
2022 $10,427 $542 $139–$2,989 $149
2023 $7,435 $534 $145–$2,697 $160
2024 $50,225 $574 $155–$3,046 $164
2025 $41,013 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Omniscient Neurotechnology America Ltd $75,489 38 payments
  2. Medexus Pharma, Inc. $25,263 11 payments
  3. DePuy Synthes Sales Inc. $1,868 49 payments
  4. Integra LifeSciences Corporation $1,550 2 payments
  5. Olympus America Inc. $1,288 3 payments
  6. Viseon, Inc. $1,255 2 payments
  7. GT Medical Technologies, Inc $1,218 8 payments
  8. Medtronic, Inc. $727 9 payments
  9. Stryker Corporation $717 8 payments
  10. Longeviti Neuro Solutions LLC $653 8 payments
  11. Other $2,155 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $93,401 29 payments
  2. Food and Beverage $11,906 131 payments
  3. Travel and Lodging $6,557 6 payments
  4. Education $318 2 payments
Products named General payments · program years 2019–2025
  1. Quicktome Software as Medical Device $30,193 23 payments
  2. Gleolan Neurological Surgery $17,573 8 payments
  3. Gleolan Neurological Surgery $7,690 3 payments
  4. Quicktome Software as a Medical Device $6,947 12 payments
  5. CODMAN CERTAS $1,550 2 payments
  6. CONNECTING TUBE $1,271 2 payments
  7. ORBEYE SURGICAL MICROSCOPE $1,271 2 payments
  8. MaxView System - Lateral Set $1,255 2 payments
  9. GammaTile $1,218 8 payments
  10. SURGIMEND $775 1 payment
  11. Other $7,263 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. NX Development Corp. $15,750 2 payments

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$96,763

Medicare's payments for the services billed

Medicare patients

122

Average age 75

Services billed

296

66 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Ischemic heart disease 38%
Diabetes 37%
Cancer 33%
Depression 31%
COPD 22%
Chronic kidney disease 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
WELIREG
  • Merck Sharp & Dohme Corporation $18
$18 — —
DALVANCE
  • AbbVie, Inc. $10
$10 — —
TEFLARO
  • AbbVie, Inc. $10
$10 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

170 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record